---
title: "Genertec Universal Medical delays dispatch of circular on revised procurement cap"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286884477.md"
description: "Genertec Universal Medical Group Company has announced a delay in dispatching a circular to shareholders regarding the revised annual cap for 2026 under its Medical Related Product Procurement Framework Agreement. The new dispatch date is set for on or before 9 June 2026, instead of the previously indicated 19 May 2026. This delay is for administrative reasons and does not affect the underlying proposal."
datetime: "2026-05-19T09:11:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286884477.md)
  - [en](https://longbridge.com/en/news/286884477.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286884477.md)
---

# Genertec Universal Medical delays dispatch of circular on revised procurement cap

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Genertec Universal Medical Group Company ( (HK:2666) ) has shared an update.

Genertec Universal Medical Group Company Limited announced a delay in sending a circular to shareholders regarding the revised annual cap for 2026 under its Medical Related Product Procurement Framework Agreement. The company now expects to dispatch the circular, which will also include the notice of its Annual General Meeting, on or before 9 June 2026 instead of the previously indicated 19 May 2026, signalling a short administrative postponement but no change to the underlying proposal.

The board, led by chairman Chen Shisu and comprising executive, non-executive and independent non-executive directors, formally approved and disclosed the new timetable. The rescheduling underscores the company’s need for additional preparation time while maintaining regulatory transparency for investors in the Hong Kong market.

**More about Genertec Universal Medical Group Company**

Genertec Universal Medical Group Company Limited is a Hong Kong–incorporated healthcare group focused on medical-related products and services, operating under stock code 2666. The company works within the broader healthcare and medical procurement sector, serving stakeholders through framework agreements and related supply arrangements.

**Average Trading Volume:** 3,971,902

**Technical Sentiment Signal:** Strong Buy

**Current Market Cap:** HK$11.24B

### Related Stocks

- [02666.HK](https://longbridge.com/en/quote/02666.HK.md)

## Related News & Research

- [05:54 ETTermHub™ Launches New Managed FHIR Offering for SDOs](https://longbridge.com/en/news/287042225.md)
- [Bayhorse Silver Adopts Semi-Annual Financial Reporting | BHSIF Stock News](https://longbridge.com/en/news/286998158.md)
- [Veros Among Initial Industry Leaders to Implement the MISMO® Common Confidence Score](https://longbridge.com/en/news/287037934.md)
- [Trump faces record-low approval on inflation as retirees struggle](https://longbridge.com/en/news/286834439.md)
- [How Investors May Respond To American Healthcare REIT (AHR) Cutting 2026 Profit Outlook After Q1 Results](https://longbridge.com/en/news/286866277.md)